Another day, another boatload for biotech. Deerfield adds $840M to rush of venture dollars
The biotech dollars just keep rolling in.
Even as the world economy faces an economic contraction unprecedented in nature, biotech venture capital firms are announcing huge new investment pots. The latest? Deerfield Management Co.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 94,200+ biopharma pros reading Endpoints daily — and it's free.